| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hookipa Pharma Inc. (HOOK) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. HOOK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 56.3K | $64.7K | - | |
| CEO | 54.3K | $62.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2020 | Sofinnova Capital VI Fcpr | 10% Owner | Sell | 41,597 | $12.61 | $524,476.53 | -0.5% | |
| Jul 20, 2020 | Sofinnova Capital VI Fcpr | 10% Owner | Sell | 12,483 | $11.94 | $149,101.95 | -0.3% | |
| Jun 29, 2020 | Sofinnova Capital VI Fcpr | 10% Owner | Sell | 3,280 | $11.78 | $38,627.58 | - | |
| Jun 29, 2020 | Sofinnova Capital VI Fcpr | 10% Owner | Sell | 3,280 | $11.78 | $38,627.58 | - | |
| Jan 29, 2020 | Matushansky Igor | Chief Medical Officer | Sell | 5,500 | $12.73 | $69,992.45 | -9.3% | |
| Jan 23, 2020 | Lilja Anders | Sr. VP, Technical Development | Sale+OE | 11,643 | $12.59 | $146,533.01 | -100% | |
| Jan 21, 2020 | Orlinger Klaus | Sr. VP, Research | Sale+OE | 8,500 | $11.93 | $101,372.77 | -100% | |
| Jan 14, 2020 | Orlinger Klaus | Sr. VP, Research | Sale+OE | 8,500 | $11.30 | $96,052.55 | -100% | |
| Dec 19, 2019 | Matushansky Igor | Chief Medical Officer | Sale+OE | 10,404 | $9.93 | $103,311.72 | -15.0% | |
| Dec 17, 2019 | Matushansky Igor | Chief Medical Officer | Sale+OE | 11,484 | $7.87 | $90,379.08 | -20.9% |